What's in Berinstein, Jeffrey's pipeline?

Berinstein, Jeffrey has 5 drugs in our index: 5 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Berinstein, Jeffrey's portfolio?

Top competitors by shared drug class: Assistance Publique - Hôpitaux de Paris, Milton S. Hershey Medical Center, Hoffmann-La Roche, Chong Kun Dang Pharmaceutical, Celgene.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/berinstein-jeffrey.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Berinstein, Jeffrey — Portfolio Competitive Intelligence Brief

Berinstein, Jeffrey pipeline: 5 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

5 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Intravenous Methylprednisolone	Intravenous Methylprednisolone	marketed
Oral prednisolone Taper	Oral prednisolone Taper	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)	Immunology / Rheumatology / General inflammation
Prednisone Oral Product	Prednisone Oral Product	marketed	Corticosteroid	Glucocorticoid receptor	Immunology, Rheumatology, Endocrinology
Cyclosporine Injection (IV)	Cyclosporine Injection (IV)	marketed	Calcineurin inhibitor	Calcineurin (protein phosphatase 2B)	Immunology
Oral Prednisone - Hospital Dose Steroids	Oral Prednisone - Hospital Dose Steroids	marketed	Corticosteroid (glucocorticoid)	Glucocorticoid receptor (GR)	Immunology / Rheumatology / General Medicine

Therapeutic area mix

Immunology · 1
Immunology / Rheumatology / General Medicine · 1
Immunology / Rheumatology / General inflammation · 1
Immunology, Rheumatology, Endocrinology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Assistance Publique - Hôpitaux de Paris · 3 shared drug classes
Milton S. Hershey Medical Center · 3 shared drug classes
Hoffmann-La Roche · 3 shared drug classes
Chong Kun Dang Pharmaceutical · 2 shared drug classes
Celgene · 2 shared drug classes
Chinese PLA General Hospital · 2 shared drug classes
Astellas Pharma Inc · 2 shared drug classes
Allergan · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for Berinstein, Jeffrey:

Cite this brief

Drug Landscape (2026). Berinstein, Jeffrey — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/berinstein-jeffrey. Accessed 2026-05-15.